e51cc36fac10a709a8617e49255206b6
CREP2
ROCHE DIAGNOSTICS GMBH·III·Ecuador ARCSA·Registered August 10, 2023
Device classification
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Brand name
- COBAS
- Commercial name
- 19-092 IVD Assay Reagents/Kits, Immunoassay, Cardiac Marker
Registration information
- Analysis ID
- e51cc36fac10a709a8617e49255206b6
- Registration date
- August 10, 2023
- Expiration date
- August 10, 2028
Manufacturer
- City
- MANNHEIM
- Country
- GERMANY
- Address
- SANDHOFER STR. 116, 68305 MANNHEIM
Product owner
- Name
- ROCHE DIAGNOSTICS GMBH
- Country
- GERMANY
Authorized representative
- Address
- AV SIMON BOLIVAR N/A Y VIA A NAYON
- Phone
- 3997100
Product use
QUANTITATIVE DETERMINATION OF CREATININE IN HUMAN SERUM, PLASMA AND URINE.
About this record
Access comprehensive regulatory information for CREP2 in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID e51cc36fac10a709a8617e49255206b6 and manufactured by ROCHE DIAGNOSTICS GMBH. The device was registered on August 10, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.